RNA-binding proteins as therapeutic targets in cancer

RNA-binding proteins (RBPs) have emerged as critical regulators of cancer progression, influencing virtually all hallmarks of cancer. Their ability to modulate gene expression patterns that promote or inhibit tumorigenesis has positioned RBPs as promising targets for novel anti-cancer therapies. Thi...

Full description

Saved in:
Bibliographic Details
Main Authors: Jennifer Jungfleisch, Fátima Gebauer
Format: Article
Language:English
Published: Taylor & Francis Group 2025-12-01
Series:RNA Biology
Subjects:
Online Access:https://www.tandfonline.com/doi/10.1080/15476286.2025.2470511
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850140077095649280
author Jennifer Jungfleisch
Fátima Gebauer
author_facet Jennifer Jungfleisch
Fátima Gebauer
author_sort Jennifer Jungfleisch
collection DOAJ
description RNA-binding proteins (RBPs) have emerged as critical regulators of cancer progression, influencing virtually all hallmarks of cancer. Their ability to modulate gene expression patterns that promote or inhibit tumorigenesis has positioned RBPs as promising targets for novel anti-cancer therapies. This mini-review summarizes the current state of RBP-targeted cancer treatments, focusing on five examples, eIF4F, FTO, SF3B1, RBM39 and nucleolin. We highlight the diversity of current targeting approaches and discuss ongoing challenges including the complexity of RBP regulatory networks, potential off-target effects and the need for more specific targeting methods. By assessing the future potential of novel therapeutic avenues, we provide insights into the evolving landscape of cancer treatment and the critical role RBPs may play in next-generation therapeutics.
format Article
id doaj-art-7c1d05bbfb2e474da253f376c8ae000f
institution OA Journals
issn 1547-6286
1555-8584
language English
publishDate 2025-12-01
publisher Taylor & Francis Group
record_format Article
series RNA Biology
spelling doaj-art-7c1d05bbfb2e474da253f376c8ae000f2025-08-20T02:29:59ZengTaylor & Francis GroupRNA Biology1547-62861555-85842025-12-012211810.1080/15476286.2025.2470511RNA-binding proteins as therapeutic targets in cancerJennifer Jungfleisch0Fátima Gebauer1Centre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, SpainCentre for Genomic Regulation (CRG), The Barcelona Institute of Science and Technology, Barcelona, SpainRNA-binding proteins (RBPs) have emerged as critical regulators of cancer progression, influencing virtually all hallmarks of cancer. Their ability to modulate gene expression patterns that promote or inhibit tumorigenesis has positioned RBPs as promising targets for novel anti-cancer therapies. This mini-review summarizes the current state of RBP-targeted cancer treatments, focusing on five examples, eIF4F, FTO, SF3B1, RBM39 and nucleolin. We highlight the diversity of current targeting approaches and discuss ongoing challenges including the complexity of RBP regulatory networks, potential off-target effects and the need for more specific targeting methods. By assessing the future potential of novel therapeutic avenues, we provide insights into the evolving landscape of cancer treatment and the critical role RBPs may play in next-generation therapeutics.https://www.tandfonline.com/doi/10.1080/15476286.2025.2470511RNA-binding proteinscancertherapeutic targetsASOSMIaptamer
spellingShingle Jennifer Jungfleisch
Fátima Gebauer
RNA-binding proteins as therapeutic targets in cancer
RNA Biology
RNA-binding proteins
cancer
therapeutic targets
ASO
SMI
aptamer
title RNA-binding proteins as therapeutic targets in cancer
title_full RNA-binding proteins as therapeutic targets in cancer
title_fullStr RNA-binding proteins as therapeutic targets in cancer
title_full_unstemmed RNA-binding proteins as therapeutic targets in cancer
title_short RNA-binding proteins as therapeutic targets in cancer
title_sort rna binding proteins as therapeutic targets in cancer
topic RNA-binding proteins
cancer
therapeutic targets
ASO
SMI
aptamer
url https://www.tandfonline.com/doi/10.1080/15476286.2025.2470511
work_keys_str_mv AT jenniferjungfleisch rnabindingproteinsastherapeutictargetsincancer
AT fatimagebauer rnabindingproteinsastherapeutictargetsincancer